pPACK-SPIKE SARS-CoV-2 S Pseudotype Lentivector Packaging Mix

Product Description

  • Based on SBI’s popular and highly cited pPACKH1 Packaging System
  • Uses codon-optimized SARS-CoV-2 “S" protein in place of VSV-G envelope protein
  • Ideal for COVID-19 research, such as neutralization assays, under BSL2 conditions
  • Package any 3rd-generation lentivector reporter of your choice, including SBI’s popular LentiLabeler reporters
  • Use with pPACK-BALD™, an envelope protein-free lentivector packaging system that is an ideal negative control

Designed to efficiently package most third-generation lentivectors, the pPACK-SPIKE SARS-CoV-2 “S" Pseudotype Lentivector Packaging Mix speeds and simplifies the preparation of lentiviral particles pseudotyped with the SARS-CoV-2 Spike glycoprotein. Based on SBI’s highly cited pPACKH1 packaging system but with a truncated SARS-CoV-2 Spike protein1 replacing the standard VSV-G envelope protein, the pPACK-SPIKE Packaging Mix consists of three plasmids that produce all of the structural and replication proteins needed to transcribe and package an RNA copy of an expression lentivector into recombinant, “Spike" pseudotyped lentiviral particles. As a result, you can conduct a range of SARS-CoV-2 studies under BSL-2 conditions, including neutralization assays, studies of virus interactions with host surface proteins, and the development of vaccines and therapeutics.

For added convenience we also offer pPACK-BALD™, an envelope protein-free lentivector packaging mix that can be used as a negative control for pPACK-SPIKE studies, or for creating lentivirus particles pseudotyped with the envelope protein of your choice.

pPACK-SPIKE SARS-CoV-2 "S" Pseudotype Lentivector Packaging Mix  is available as stand-alone packaging mixes with sufficient plasmids for 10 reactions (standard size) or 25 reactions (XL), as well as in a convenient Combo Kit that includes PureFection™ Transfection Reagent and PEG-it Virus Precipitation Solution.

How It Works

pPACK-SPIKE is easy to use - simply co-transfect the pPACK-SPIKE Plasmids and your lentivector construct into 293TN producer cells or other lentiviral production cells, isolate pseudoviral particles with an optional concentration step, and conduct your studies.

 

Available pPACK-SPIKE S protein variants

Catalog Number Spike Variant WHO label  Spike Protein Mutation
CVD19-500A-1-SBI SARS-CoV-2 “S” Pseudotype   Original Wuhan-Hu-1 strain
CVD19-530A-1-SBI D614G Mutant    D614G
CVD19-560A-1-SBI N501Y Mutant    N501Y
CVD19-590A-1-SBI B.1.1.7 (UK) Variant  Alpha ΔH69/V70, ΔY144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
CVD19-580A-1-SBI B.1.351 (S.A.) RBD Mutations Beta K417N, E484K, & N501Y
CVD19-600A-1-SBI B.1.351 (S.A.) S1 Mutations (RBD+D614G) Beta K417N, E484K, N501Y, & D614G
CVD19-640A-1-SBI B.1.351 (S.A.) complete spike mutations Beta ΔH69/V70, Q52R, E484K, D614G, Q677H, F888L
CVD19-610A-1-SBI B.1.429 (CAL.20C) Variant  Epsilon  S13I, W152C, L452R, & D614G
CVD19-620A-1-SBI B.1.525 Variant  Eta ΔH69/V70, Q52R, E484K, D614G, Q677H, & F888L
CVD19-630A-1-SBI P1 Variant Gamma L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F
CVD19-650A-1-SBI B.1.617.2 Variant Delta T19R, G142D, ΔE156-157, R158G, L452R, T478K, D614G, P681R, D950N
CVD19-660A-1-SBI B.1.1.529 Variant Omicron

A67V, Δ69-70, T95I, Δ142-144, Y145D, Δ211, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S,Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F

 

Price
880,00 €
you need any help?

Please contact:

Maria Schröder

Tel. +49 (0) 6221 71415 16

info@biocat.com

Image